IP Protection in biopharma safeguards scientific discoveries, patents, and processes, ensuring safe and ethical drug development. It minimizes risks of counterfeiting while strengthening patient confidence. By rewarding innovation, it encourages further breakthroughs, enabling companies to bring advanced therapies and novel treatment options to patients with rare diseases and chronic ... https://sites.google.com/view/xellera-therapeutics/home